Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Icu Medical (ICUI) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Icu Medical (ICUI) over the last 17 years, with Q3 2025 value amounting to -$25.7 million.

  • Icu Medical's Cash from Financing Activities fell 14748.55% to -$25.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$285.2 million, marking a year-over-year decrease of 41431.89%. This contributed to the annual value of -$55.8 million for FY2024, which is 5509.05% down from last year.
  • Icu Medical's Cash from Financing Activities amounted to -$25.7 million in Q3 2025, which was down 14748.55% from -$195.0 million recorded in Q2 2025.
  • In the past 5 years, Icu Medical's Cash from Financing Activities ranged from a high of $1.6 billion in Q1 2022 and a low of -$195.0 million during Q2 2025
  • Its 5-year average for Cash from Financing Activities is $65.9 million, with a median of -$8.2 million in 2024.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first soared by 5506390.0% in 2022, then crashed by 177803.35% in 2025.
  • Over the past 5 years, Icu Medical's Cash from Financing Activities (Quarter) stood at -$15.3 million in 2021, then surged by 32.03% to -$10.4 million in 2022, then rose by 24.42% to -$7.8 million in 2023, then fell by 4.36% to -$8.2 million in 2024, then plummeted by 213.62% to -$25.7 million in 2025.
  • Its Cash from Financing Activities stands at -$25.7 million for Q3 2025, versus -$195.0 million for Q2 2025 and -$56.3 million for Q1 2025.